Market Research Trends

The global bioabsorbable stents market is expected to grow from US$ 159.6 million in 2021 to US$ 248.5 million by 2032, at a CAGR of 4.2%. A recent study reveals that in 2021, coronary artery stents will account for approximately 76.3% of the global bioabsorbable stents market. Unlike regular stents, bioabsorbable stents are made from materials that are easily absorbed by the body, and function similarly to regular medical stents. The market for bioabsorbable stents is anticipated to be worth US$ 165.4 million by the end of 2022, and is poised to reach a value of around US$ 350 million by the same year. Bioabsorbable polymeric stents have gained popularity due to their ability to treat coronary artery disease (CAD) without producing long-term complications. The study shows that biodegradable polymers and copolymers are the preferred materials for bioabsorbable stents, and have undergone significant improvements in material processing, mechanical performance, and biodegradability. Key ...

The bioabsorbable stents market was worth US$ 159.6 million in 2021 and is predicted to be worth US$ 165.4 million by the end of 2022. The market is expected to grow at a CAGR of 4.2%, hitting US$ 248.5 Million by 2032. According to a recent study, coronary artery stents will account for around 76.3% of the worldwide bioabsorbable stents market in 2021. Bioabsorbable stents function like normal medical stents. The main difference between regular stents and bioabsorbable stents is the material which is used in their manufacturing; bioabsorbable stents use material which is easily absorbed in the body. The global bioabsorbable stents market is poised to reach a value of around US$ 350 Million by the end of 2022 and is anticipated to grow at a robust CAGR during the period of forecast of 2017 to 2022. Coronary artery disease (CAD) is the leading cause of death worldwide. Bioabsorbable polymeric stents have grown in popularity due to its ability to cure CAD without producin...